Strategic speaking Pembroke Consulting represents a focused opportunity to upsell premium, high-impact speaking engagements tied to pharmaceutical economics and drug channel strategy, expanding to corporate and policy-facing events that require expert-level insights.

Executive audience Dr. Fein’s role as a leading authority and president of Drug Channels Institute positions the firm to target C-suite and policy professionals seeking advanced, data-driven healthcare narratives, enabling targeted outreach to decision-makers.

Recurring revenue With a revenue range of 10M to 25M and a lean team, there is potential to monetize repeat engagements, advisory services, and customized workshops for pharma clients seeking ongoing education and strategy updates.

Tech enablement Leverage existing tech stack (Google Workspace, analytics, and web presence) to scale marketing to healthcare executives, automate lead nurturing, and deliver virtual or hybrid keynote experiences to a broader audience.

Market alignment Position Pembroke as a bridge between industry trends and practical business impact, targeting pharmaceutical companies, policy leaders, and healthcare organizations investing in cost-effective education and strategy development.